Cargando…
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
Valvular heart disease is a common disease often necessitating valve replacement. Mechanical heart valves (MHVs) are often used in younger patients because of their longer durability. Their main disadvantage is the need for lifelong anticoagulation. Warfarin is considered a standard treatment, but i...
Autores principales: | Langenaeken, Tom, Vanoppen, Arnaud, Janssens, Fien, Tanghe, Loes, Verbrugghe, Peter, Rega, Filip, Meuris, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419922/ https://www.ncbi.nlm.nih.gov/pubmed/37568386 http://dx.doi.org/10.3390/jcm12154984 |
Ejemplares similares
-
In vivo performance of a tri-leaflet mechanical heart valve prosthesis in an ovine model
por: Langenaeken, Tom, et al.
Publicado: (2023) -
Apixaban in a porcine model of mechanical valve thrombosis in pulmonary position—a pilot study
por: Van Hoof, Lucas, et al.
Publicado: (2022) -
Avoiding oversizing in sutureless valves leads to lower transvalvular gradients and less permanent pacemaker implants postoperatively
por: Szecel, Delphine, et al.
Publicado: (2022) -
Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement
por: Verstraete, Andreas, et al.
Publicado: (2021) -
Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)